Summary of clinical end points derived from risk assessment models according to CMML phenotype
| Risk assessment based on CMML phenotype, survival data (years) . | OS, c-index . | LFS, c-index . | AML risk, c-index . |
|---|---|---|---|
| MDS-CMML | |||
| CPSS-Mol: low risk: 6.8 | IR-1: 5.05 | IR-2: 2.87 | high risk: 1.9 | 0.7128 | 0.7067 | 0.666 |
| IPSS-M: VLR: NR | low risk: 6.5 | MLR: 3.49 | MHR: 2.87 | high risk: 2.96 | VHR: 1.37 | 0.7022 | 0.6918 | 0.6831 |
| MMM: low risk: 6.8 | IR-1: 5.44 | IR-2: 3.17 | high risk: 1.9 | 0.6347 | 0.6337 | 0.5714 |
| GFM: low risk: 5.05 | IR: 3.1 | high risk: 1.53 | 0.5828 | 0.5696 | 0.4293 |
| MPN-CMML | |||
| CPSS-Mol: low risk: None | IR-1: 2.88 | IR-2: 3.82 | high risk: 1.71 | 0.612 | 0.6474 | 0.5898 |
| IPSS-M: VLR: 4.37 | low risk: 3.74 | MLR: 3.94 | MHR: 2.16 | high risk: 1.33 | VHR: 1.1 | 0.6706 | 0.6774 | 0.5499 |
| MMM: low risk: 4.37 | IR-1: 3.74 | IR-2: 1.79 | high risk: 1.81 | 0.4874 | 0.4971 | 0.4987 |
| GFM: low risk: 3.94 | IR: 2.61 | high risk: 1.71 | 0.5696 | 0.5683 | 0.4752 |
| Risk assessment based on CMML phenotype, survival data (years) . | OS, c-index . | LFS, c-index . | AML risk, c-index . |
|---|---|---|---|
| MDS-CMML | |||
| CPSS-Mol: low risk: 6.8 | IR-1: 5.05 | IR-2: 2.87 | high risk: 1.9 | 0.7128 | 0.7067 | 0.666 |
| IPSS-M: VLR: NR | low risk: 6.5 | MLR: 3.49 | MHR: 2.87 | high risk: 2.96 | VHR: 1.37 | 0.7022 | 0.6918 | 0.6831 |
| MMM: low risk: 6.8 | IR-1: 5.44 | IR-2: 3.17 | high risk: 1.9 | 0.6347 | 0.6337 | 0.5714 |
| GFM: low risk: 5.05 | IR: 3.1 | high risk: 1.53 | 0.5828 | 0.5696 | 0.4293 |
| MPN-CMML | |||
| CPSS-Mol: low risk: None | IR-1: 2.88 | IR-2: 3.82 | high risk: 1.71 | 0.612 | 0.6474 | 0.5898 |
| IPSS-M: VLR: 4.37 | low risk: 3.74 | MLR: 3.94 | MHR: 2.16 | high risk: 1.33 | VHR: 1.1 | 0.6706 | 0.6774 | 0.5499 |
| MMM: low risk: 4.37 | IR-1: 3.74 | IR-2: 1.79 | high risk: 1.81 | 0.4874 | 0.4971 | 0.4987 |
| GFM: low risk: 3.94 | IR: 2.61 | high risk: 1.71 | 0.5696 | 0.5683 | 0.4752 |
MMM: Mayo Molecular Model. GFM: Groupe Francophone des Myelodysplasies Model. NR: not reached. VLR: very-low risk; IR-1: intermediate-1; IR-2: intermediate-2; MLR: moderate-low risk; MHR: moderare-high risk; VHR: very-high risk.
Statistically significant results are shown in bold.